Skip to main content

Table 1 Patient demographics, symptoms, and PAVMs treated in groups A and B

From: Embolisation of pulmonary arteriovenous malformations using high-frequency jet ventilation: benefits of minimising respiratory motion

Group Number of patients Demographics Symptoms Number of PAVMs treated PAVM location Embolisation devices
A (HFJV) 5 Age 47.2 ± 11.7 years (34–57 years)
2 males, 3 females
4/5 (80%)
1 prior TIA
3 dyspnoea
12 simple RLL (n = 4)
RML (n = 1)
RUL (n = 1)
LLL (n = 4)
LUL (n = 2)
6.5-mm MVP (n = 4), vascular plug (n = 5), coils (n = 3)
B (IPPV) 10 Age 41.5 ± 12.4 years (27–65 years)
5 male, 5 female
7/10 (70%)
1 prior TIA
6 dyspnoea
15 (14 simple, 1 complex) RLL (n = 3)
RML (n = 5)
RUL (n = 2)
LLL (n = 3)
LUL (n = 2)
6.5-mm MVP (n = 4), vascular plug (n = 3), coils (n = 8)
  1. Ages are given as mean ± standard deviation (range). HFJV High-frequency jet ventilation, IPPV Intermittent positive pressure ventilation, LLL/LUL Left lower/upper lobes, MVP Microvascular plug, RLL/RML/RUL Right lower/middle/ upper lobes, TIA Transient ischemic attack